Fifty-five dogs were exposed by inhalation to graded activity levels of 144 CeCl 3 , a relatively soluble form of the &beta;-emitting radionuclide. A large portion of the 144 Ce translocated from lung to liver and skeleton. Significant radiation doses were delivered to the respiratory tract, liver, and skeleton; however, the liver received the greatest cumulative absorbed dose. Liver tumors were the most frequently observed neoplasms in these exposed dogs and included 7 primary hepatic hemangiosarcomas, 1 cholangiocarcinoma, 1 hepatocellular carcinoma, 1 fibrosarcoma, 4 biliary cystadenomas, and 1 fibroma. The dose to the liver in these dogs ranged from 11 to 250 Gy with a median of 57 Gy. Autoradiographs showed a relative uniform distribution of & b e t a ; dose to the liver. All the malignant tumors and 1 cystadenoma were primary causes of death. The morphologic features of the hemangiosarcomas and associated hepatic lesions were similar to those described for hemangiosarcomas induced in people exposed to Thorotrast. Biliary cystadenomas were associated with degenerative lesions in the liver but not with other neoplasms in the liver. These results indicate that the liver is an important target organ for effects from internally deposited 144 Ce.
INTRODUCTION
The role of internally deposited radionuclides in the induction of hepatic disease and hepatic neoplasia in humans is only well established for thorium dioxide (Thorotrast). A significant proportion of patients who received this radiographic contrast medium intravascularly developed severe degenerative liver disease and primary hepatic tumors (6, 20, 22, 31) . Hepatic hemangiosarcomas comprise a high percentage of these tumors (19) . Liver neoplasms associated with Thorotrast administration develop with long latent periods (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) yr) following a radiation doses to the liver from thorium estimated at 1.5-32 Gy (16, 22, 31) .
A series of long-term studies in progress at the Inhalation Toxicology Research Institute have been designed to assess the biologic effects of inhaled radionuclides that are found in high concentrations in the nuclear fuel cycle and that might be released in the event of a nuclear accident. Among the radionuclides studied is the fission product radionuclide, 144Ce, a (3-particle-emitting radionuclide with a physical half-life of 284 days. Because of the solubility of '44CeC13, the inhaled 144Ce is translocated fairly rapidly from the lung to liver, where it remains with a long biological half-time and an effective half-time close to the radioactive half-life. The general biologic effects of inhaled 144CeCl, in dogs have been described (14) . The present report describes, in more detail, the hepatic neoplasms seen in these dogs, as well as other hepatic lesions related to 144Ce exposure, and compares these findings with those seen in people exposed to Tho- rotrast.
MATERIALS AND METHODS
The experimental design, details of exposure dosimetry, and biological effects for this life-span study have been reported (14) . In brief, 55 beagle dogs (27 females and 28 males) received single, nose-only exposures to aerosols of 144CeCl3 (an equilibrium mixture of 144Ce with its progeny 144Pr) in a CsCI solution. Aerosol concentrations and exposure times were adjusted to achieve longterm retained burdens (LTRBs) that ranged from 0.096 to 13.3 MBq/kg body weight. The LTRB was the fraction of the initial body burden remaining after a rapid clearance lasting 1-2 days was complete and was determined for each dog by whole-body counting. Fifteen unexposed dogs served as controls. The results of a companion study to determine the metabolism and dosimetry of inhaled 144CeCl, in dogs have also been published (3) .
Dogs used in this study were from the Inhalation Toxicology Research Institute colony. The dogs were exposed to the I44CeC13 aerosol at 12-14 mo of age; control dogs were exposed to the aerosol vehicle at the same age. The first dog was exposed in 1966, and the last dog died in 1984. Guidelines for the care and use of the dogs were approved by the institutional Animal Care Committee existing at the time. Each dog was observed twice daily until death and examined thoroughly at least yearly to determine health status. Blood was drawn at least annually for routine hematology and clinical chemistry, including 2 enzymes related to hepatic function, serum alkaline phosphatase (SAP), and serum alanine aminotransferase (ALT). The SAP and ALT were determined using a semiautomated analyzer (Sequential Multiple Analyzer 12/30 Technicon Instruments, Tarrytown, NY). All spontaneously occurring diseases and conditions were treated using generally accepted veterinary practices.
Terminally ill dogs and dogs in pain that could not be controlled by medication were euthanized with pentobarbital anesthesia and cardiac bleedout. Complete necropsies were performed on all dogs in the study. Selected tissues were analyzed for I.+4Ce, and all major organs and lesions were sampled for histological examination. Numerous random sections were taken from the liver and F~G. 1.-General pattern of disease occurrence in dogs after inhalation to 144CeC'3. Arrows indicate range of doses to organ and range of survival times. from hepatic lesions. Tissues for histopathologic examination were fixed in 10% buffered formalin, embedded in paraffin, sectioned at 5 Rm, and stained with hematoxylin and eosin. Autoradiography and special stains were performed as deemed necessary. Autoradiographs were prepared using a liquid emulsion (NTB2, Eastman Kodak, Rochester, NY) and development after a 3-wk exposure. Immunohistochemical staining for Factor VIII was performed by using an avidin biotin complex method.l The primary antibody was made in the mouse (Dako, Carpenteria, CA). The chromogen was diaminobenzidine tetrahydrochloride. Controls included substituting the primary antisera with nonimmune sera and omitting the primary antibody.
RESULTS
Inhalation of 144CeCl3 resulted in deposition of 144 Ce throughout the respiratory tract. There was rapid mucociliary clearance of 40-50% of the material deposited in the upper respiratory tract and large airways. Material cleared in this manner was swallowed, passed through the gastrointestinal tract, where it was poorly absorbed, and excreted in the feces. Because '~CeCl3 is relatively soluble, much of the 144 Ce deposited in the lung was redistributed via the blood and deposited in the liver and skeleton, with peak concentrations of 144Ce occurring at 8 days after exposure. Thereafter, 144Ce disappeared from these tissues at a rate very close to the physical half-life of the radionuclide, 284 days. Those tissues that received significant doses of (3-particle radiation were liver, lung, skeleton, and bone-associated tissues (marrow, oral mucosa, nasal mucosa). Ninety-two percent of the potential infinite dose to the liver was delivered by 1,000 days after exposure. For dogs that lived longer than 1,000 days after exposure, the average cumulative 13 dose for the liver was calculated to be 59 Gy per MBq 144 Ce LTRB/kg body weight. The corresponding values for other tissues were nasal mucosa, 30; lung, 24; skeleton, 18; oral mucosa, Autoradiographs of the liver from 10 of the 15 dogs that died less than 2 yr after 144CeC13 exposure were examined. Four dogs that died at 21, 22, 31, and 144 days after exposure had silver grains uniformly distributed over the liver parenchyma. In the remaining dogs (dying at 31, 138, 309, 336, 375, and 510 days after exposure), the distribution of activity in the liver was uniform except for foci of mildly increased density located over sinusoidal macrophages containing pigment that was both ironand periodic acid-Schiff (PAS)-positive. These findings indicate a relatively uniform distribution of 144Ce in the liver resulting in uniform (3 irradiation of the liver.
The biological effects were generally related to the tissue and organ distribution of 144Ce and to the radiation dose and time after exposure. These effects could be grouped into 3 general categories: early nonneoplastic diseases, early neoplasia, and late neoplasia ( Fig. 1 ). At very early times (20-45 days after exposure), dogs with high LTRB (-7.8 MBq/kg) died with hematologic dyscrasias related to bone marrow necrosis and atrophy. Some dogs with high LTRB, however, did not die of hematologic dyscrasias but survived to die several hundred days later of radiation pneumonitis or hepatocellular degeneration, necrosis, and atrophy. Early neoplastic diseases were characterized by neoplasms related to 144Ce deposited in bone or liver. Only 1 primary cancer of bone developed, but bone marrow tumors and tumors of oral mucosa, epithelium closely associated with bone, were prominent 4.6-6.0 yr after exposure. The late neoplasia category included tumors of nasal mucosa, liver, and lung, which occurred 7.5 yr or more after exposures. Primary hepatic neoplasms were the most common neoplasms in dogs exposed to 144CeCl, (Table I) . Thirteen of the 39 dogs (33%) surviving 2 yr or more after exposure (long-term survivors) had hepatic neoplasms. Nine had malignant neoplasms, and 5 had benign (2 had both benign and malignant). The malignant neoplasms included 7 primary hepatic hemangiosarcomas, 1 hepa- --Characteristics of hepatic hemangiosarcomas and associated hepatic lesions in dogs exposed by inhalation to 144CeC'3-° -= Absent; + = relative severity of frequency of finding. b Immunohistochemical detection of Factor VIII antigen: -= staining absent; + = staining present; ND = not done. tocellular carcinoma, and 1 cholangiocarcinoma. In every dog that developed a malignant hepatic neoplasm, the tumor was the primary cause for the death of the animal. Two dogs had 2 primary liver neoplasms; however, the second neoplasm was incidental in each case. Five dogs had benign liver tumors; 4 of these were biliary cystadenomas. Two of the biliary cystadenomas were quite large, contributing to death in one case and causing death in the other. Two of the 15 control dogs had benign hepatic neoplasms. The hemangiosarcomas were characterized in more detail to determine their similarity to the hemangiosarcomas in Thorotrast patients.
In dogs with primary hepatic hemangiosarcoma, the course of the disease after clinical recognition was often rapid. Anemia was usually the first clinical sign observed. This was seen as early as 146 days before death as a characteristic microangiopathic, hemolytic anemia (26) . Five animals had persistently elevated SAP values (> 112 IU/L) and 2 had increased ALT (>85 IU/L) values, which appeared earlier than signs of anemia, in one case as early as 2 yr before death. Five dogs with hepatic hemangiosarcomas died or were euthanized because of hemoperitoneum resulting from rupture of a tumor mass. The principal morphologic features in the liver of the dogs with hemangiosarcoma of the liver are shown in classified as massive, multinodular, or mixed massive and multinodular. The massive type was characterized by a large hemorrhagic mass up to 18 cm in diameter that filled or expanded 1 liver lobe. The multinodular neoplasm had numerous hemorrhagic nodules, measuring up to 1 cm in diameter, scattered through all liver lobes. In all cases, the neoplasms were easily visible on the capsular surface of the liver. In 5 dogs, the tumor masses were friable, not encapsulated, and had ruptured, resulting in marked peritoneal hemorrhage.
The hemangiosarcomas were characterized by 2 cellular types, either spindle or polygonal cells. The spindle cells had elongated nuclei and extended cytoplasm with indistinct cytoplasmic borders (Fig. 2 ). Occasional nuclei contained a prominent nucleolus, but mitotic figures were rare. The polygonal cells contained round to oval nucleoli that frequently had large or multiple nuclei (Fig. 3 ). In some tumors, mitotic figures were frequent. The cytoplasm was distinct, but usually not abundant. The polygonal cells were generally much more anaplastic than the spindle cells.
The histologic pattern of the hemangiosarcoma was classified as sinusoidal, capillary, or cavernous. The sinusoid pattern was characterized by a proliferation of spindle cells along sinusoids causing varying degrees of sinusoidal dilation and atrophy of hepatocytic cords ( 4). In the larger masses, the hepatic architecture was destroyed, and small spindle cell-lined slits or spaces were formed by the neoplastic tissue, or there were large foci of hemorrhagic necrosis. The capillary pattern was characterized by polygonal cells that grew in rather loose masses, which formed small, microscopic spaces (Fig. 5 ). The polygonal cells were frequently anaplastic with multiple nucleoli and giant nuclei. Hemorrhage and necrosis in the center of the masses were frequent. The cavernous pattern was characterized by anaplastic polygonal cells that formed large cavernous blood-filled spaces (Fig. 6 ). In some foci, thick collagenous septa were present lined by flattened cells. In other foci, macroscopic blood-filled spaces were lined by multilayered anaplastic polygonal cells. Other features of the tumor tissues included erythrophagocytosis by neoplastic cells in one case and extramedullary hematopoiesis in varying degrees in all cases.
Immunohistochemical staining of the tissue for Factor
Fm. 5.-Capillary histologic pattern of hepatic hemangiosarcoma of a dog that died 2,467 days after inhalation of 'a-'CeCl3. H&E.
X480.
FiG. 6.-Cavernous histologic pattern of hepatic hemangiosarcoma of a dog that died 1,735 days after inhalation of '44CeC13. H&E.
VIII antigen showed positive staining in tumor cells in 4 of the 6 hemangiosarcomas examined. The 4 positive samples included examples of each histologic pattern: cavernous, capillary, and sinusoidal. The neoplasm that demonstrated erythrophagocytosis, a purported indication of Kupffer cell origin, was one of the neoplasms that stained positive for Factor VIII antigen. This result provides evidence that at least 4 of the hemangiosarcomas were derived from endothelial cells and not from Kupffer cells, as was the case with many Thorotrast-induced hepatic tumors in rats (33) .
The hepatic parenchyma away from the hemangiosarcomas often contained numerous lesions (Table II) , but only hepatocellular hyperplasia and nodular hyperplasia, present in nearly all dogs, were frequent. Sinusoid dilation and peliosis (Fig. 7 ), sinusoidal cell hyperplasia (Fig.  8 ), and sinusoidal fibrosis, purported precursor changes associated with Thorotrast-induced hemangiosarcomas in humans (24, 29) , were infrequently found together in any X360. one dog. However, each dog had at least one of these putative precursor changes. Hepatocellular degeneration and biliary hyperplasia, changes not associated with hemangiosarcoma in humans, were present in many of the 7 dogs with hemangiosarcoma.
Review of the livers of all the dogs dying at early times, before the first dog with hepatic hemangiosarcoma, but with high doses to the liver, showed lesions consistent with radiation injury (34) but not with precursors of hemangiosarcoma. At 138-336 days after exposure, hepatic sinusoidal cells frequently contained a PAS-positive, iron-positive pigment. At 309-336 days after exposure, fibrosis of central veins and portal triads were noted along with a moderate biliary hyperplasia. Marked hepatic cellular degeneration and centrolobular hepatocyte atrophy was also present at this time, resulting in the death of the dogs. At 510 days after exposure the fibrosis persisted, and at 874 days an additional dog died of marked hepatocellular degeneration and atrophy.
Lesions classified as biliary cystadenomas were identified in 4 exposed dogs (Table I) . These lesions developed in dogs that had clinical liver disease, as indicated by elevated SAP (from 112 to 470 IU/L) and ALT (from 75 to 596 IU/L) for 1-3 yr before death and hepatomegaly 3 wk to 3 yr before death. At necropsy, livers had moderate hepatocellular degeneration, minimal nodular hyperplasia, and moderate biliary hyperplasia and lipogranulomata. The degeneration was characterized by hydropic and fatty change and single-cell necrosis.
These neoplasms were characterized grossly by multiloculated cysts that ranged from 4 to 10 cm in diameter and distorted the normal hepatic outline. The weight of the liver was greatly increased. In one case in which the cystadenoma was the primary cause of death, the liver was 4 times normal weight.
Histologically, the biliary cystadenomas were circumscribed, but expansive, cystic lesions with nests of epithelial cells extending outward between hepatic cords (Fig. 9 ). No connective tissue capsule and few inflammatory cells were present. The cysts comprised many 
H&E.
X240. microcystic cavities. Trabeculae of the microcavities were fine, but some contained trapped hepatocytes. Cavities were lined by a moderately cellular, simple cuboidal epithelium.
Biliary cysts, very similar to the biliary cystadenomas, were noted in 6 exposed dogs. One of these had clinical liver disease, as indicated by an elevated SAP (114-140 IU/L), but not hepatomegaly. At necropsy, all 6 dogs had moderate hepatocellular degeneration, mild biliary hyperplasia, and marked nodular hyperplasia.
These cystic lesions were classified as simple biliary cysts based on histologic criteria. The cysts were sharply delineated, nonexpansible lesions with a connective tissue capsule (Fig. 10) . The cyst comprised a single or a few cavities. Trabeculae of the cysts were thick and collagenous. Inflammatory cells were usually present in the cyst wall. The cavity was lined by simple cuboidal or flattened epithelium composed of few epithelial cells. The biliary cysts occurred earlier in the life span than the cystadenomas and were generally smaller. Thus, the cysts may be precursor lesions to the cystadenomas. However, no evidence indicates that the cystadenomas are precursors for malignant neoplasms.
The hepatocellular carcinoma was present as multiple firm nodules throughout the liver. Histologically it was poorly differentiated and composed of irregular masses of pleomorphic cells without a recognizable pattern of cell arrangement. Neoplastic cells included both very large polyhedral cells with intensely eosinophilic cytoplasm and smaller elongated cells with slightly eosinophilic, vacuolated cytoplasm; small numbers of multinucleate tumor cells were present (Fig. 11 ). Neoplastic tissue infiltrated surrounding hepatic parenchyma but did not metastasize.
The cholangiocarcinoma comprised a major mass involving 2 liver lobes. Microscopically, the tumor was composed of epithelial cells arranged in a tubular pattern. Neoplastic cells had palely eosinophilic cytoplasm and large, round to oval, vesicular nuclei (Fig. 12 ). The neoplasm was highly infiltrative and metastasized to lung and local lymph nodes.
The relationship between cumulative 13 dose to liver and the time of death from hepatic tumors is shown in Table I and Fig. 1 . The 5 hepatic hemangiosarcomas that developed in livers with 13 doses of 110 Gy or greater were present in dogs that died within 1,735-2,467 days after exposure. The 2 hepatic hemangiosarcomas that developed at lower dose became apparent at time intervals (4,194 and 4,878 days) inversely proportional to dose. The hepatocellular carcinoma and cholangiocarcinoma developed with long latent periods in dogs that received relatively low doses of radiation to the liver. The biliary cystadenomas were seen in dogs dying with greater doses to liver than those dying with carcinomas of the liver.
DISCUSSION
The incidence of spontaneous malignant liver tumors in dogs is generally quite low. In a study of the pet dog population of Alameda County, California, 1.8% of all malignant tumors in dogs were of hepatic origin (7) . Investigators at the Animal Medical Center in New York City found malignant liver neoplasms in 0.9% (110/ 12,245) of all dogs necropsied; these tumors included hepatocellular carcinomas (0.47%), bile duct tumors (0.20%), carcinoids (0.12%), and sarcomas (0.11 %) (23) .
At the University of California Davis, School of Veterinary Medicine, hepatocellular carcinomas were diagnosed in 0.63% of necropsies (27) . Primary hepatic hemangiosarcoma has been reported in 0.016% (18/ 112,000) of dogs examined; the relative frequency of this tumor in dogs was calculated to be 25-100 times that in humans (25) . At the Inhalation Toxicology Research Institute, 88 control dogs on life-span studies, including the 15 in this study, have developed 3 primary liver tumors, 1 biliary cystadenoma and 2 adenomas.
Although the liver neoplasms observed in dogs exposed by inhalation to '~CeCl3 were not different in appearance from spontaneously occurring hepatic tumors, the very high incidence of these tumors and the preponderance of hemangiosarcomas along with the (3 dose to the liver suggest a causal relationship between 144Ce exposure and the occurrence of liver tumors. In addition, hemangiosarcomas of several organs have been induced in dogs by internally deposited (3-emitting radionuclides, including lung (13) , lymph nodes (15), bone (1, 12) , and bone-associated mucosa (1), as well as liver. These reports emphasize the association of 13 irradiation with hemangiosarcoma of numerous tissues.
Studies in other species have also linked 144Ce exposure to the development of liver tumors (21) . Rats injected intraperitoneally with 144Ce in chloride solution have been observed to have an incidence of hepatic tumors that increased with increasing radiation dose: rats receiving 18.5 MBq/kg had a 3.4% incidence of liver tumors, whereas 37.5% of rats receiving 37 MBq/kg developed hepatic tumors; the incidence of liver tumors in control rats was 1.5%. Tumors included bile duct and parenchymal cell tumors, as well as hemangioendothe-liomas. In Chinese hamsters injected intraperitoneally with 144Ce citrate, 4 of 11 animals receiving doses of 18.5 kBq/g or greater developed hepatic neoplasms. These included 3 benign hepatocellular neoplasms and 1 bile duct adenoma (4) .
Hemangiosarcomas that develop in the livers of humans exposed to Thorotrast, vinyl chloride, or arsenic are apparently multicentric in origin. A precursor stage characterized by sinusoidal dilation to peliosis, focal hepatocyte hyperplasia, activation and increased numbers of sinusoid cells, proliferation and lobular enlargement, and perisinusoidal fibrosis has been identified in patients with hepatic hemangiosarcoma following exposure to these compounds (24, 29) . Transition of the precursor lesion to hemangiosarcoma has been described. Whether or not 144Ce-induced hepatic hemangiosarcomas were multicentric in origin was not evident in the present study; in 2 cases, only a single tumor mass was located. However, the lesions described as precursor or transition lesions in humans were seen in dogs in this study.
The liver neoplasms seen in the dogs that inhaled 144CeCl3 are similar to those seen in beagle dogs that inhaled 238Pu02 in that a large majority were sarcomas, either hemangiosarcoma or fibrosarcomas (11) . The liver neoplasms seen in these 2 studies differ in distribution of phenotype from those seen in beagle dogs injected with 239pu or 24'Am (28) . In the latter studies, most neoplasms were bile duct carcinomas with a minority of fibrosarcomas. The reasons for this difference are not clear. Total doses to the liver were similar in the studies with the aemitting radionuclides. The hepatic dose-rate pattern differed between the inhalation route and the intravenous injection route of exposure. With injection, the initial dose rate is high and then decreases as the radionuclide is quickly absorbed from the blood. With the inhalation exposures, the radionuclides were retained in the lung, albeit relatively briefly, before translocation to the blood and then the liver.
The relationship between '44CeC13 exposure and degenerative or proliferative hepatic lesions was somewhat difficult to evaluate in the present study, as there did not appear to be an obvious correspondence between the severity of these lesions and the 13 dose to the liver. However, similar degenerative liver lesions have been seen in other studies of 144Ce effects. In one group of 49 dogs injected intravenously with 144Ce, all dogs dying more than 1,000 days after injection had hepatic degeneration; in 4 dogs, this was considered to be the primary cause of death (10) . One dog developed an unidentified hepatic neoplasm. All rats given 38 MBq/kg 144Ce intraperitoneally and surviving more than 200 days postinjection developed cirrhosis of the liver, often accompanied by ascites and icterus (21) . Liver cirrhosis was characterized by extensive venous and capillary damage, necrosis of hepatocytes, fibrosis, and proliferation of intrahepatic bile ducts and liver parenchymal cells. Nodular hyperplasia, focal hepatic degeneration, and biliary hyperplasia were reported in many Chinese hamsters given 144Ce intraperitoneally (4) . Hyperplastic and degenerative changes were most severe in animals receiving the highest doses of the radionuclide.
In the present study, hyperplastic nodules in 144CeCl3exposed dogs did not differ in microscopic appearance from similar lesions in control dogs. Exposed dogs developed these nodules more frequently and at an earlier age than did control dogs. Hyperplastic nodules are not an uncommon finding in old dogs, but little is known of their etiology or pathologic significance (2, 9) .
Biliary cysts and cystadenomas in exposed dogs were similar to those described in old dogs (18) ; however, the severity and frequency of these lesions in 144CeCl,-exposed dogs were correlated with relatively high radiation doses (>30 Gy) and moderate hepatocellular degeneration. Similar cystic lesions have been described in dogs injected with 239Pu or 241 Am (28) and demonstrate a similar relationship to dose and accompanying lesions. It has been suggested that biliary cystadenomas in the dog do not represent true neoplastic lesions (18) . Similar suggestions have been made for chemically induced cystadenomas in the rat, where extensive observations have been made (5, 8) . Because of these suggestions and the association of the cystadenomas with high radiation doses, these lesions should not be used for the assessment of liver cancer risk at low doses.
The distribution of 144Ce seen in liver autoradiographs in the present study was somewhat similar to the distribution of tetravalent 239pu citrate given intravenously in the dog (28) . Plutonium-239 was initially deposited in I the hepatocytes in a uniform manner. At times in excess of 2-3 mo after exposure, increased activity was seen in some of the sinusoidal macrophages; this activity was always associated with hemosiderin deposits. Plutonium-239 was translocated more rapidly in animals given higher doses of the radionuclide, and movement of 239Pu into macrophages was presumed to occur at the time of hepatocyte death. In the present study, it was apparent that some degree of translocation of 144Ce from hepatocytes to macrophages or Kupffer cells also occurred, probably as a sequel to hepatocyte necrosis. Two dogs that died of hepatic degeneration following 144CeC'3 inhalation and presumably had the most hepatocytic death had the most pronounced sinusoidal localization of 144Ce. Despite localization of 239pu in sinusoidal macrophages, Pu-exposed dogs were not reported to develop hepatic hemangiosarcomas. Ten percent of 239Pu-injected dogs surviving to more than 1,000 days of age developed intrahepatic bile duct tumors; only 20% of these tumors were malignant. Additional hepatic changes seen in 239Pu-exposed dogs included liver atrophy, multiple hyperplastic nodules, and biliary hyperplasia (28) .
While both 144Ce and 239Pu in the dog appear to cycle through the hepatocytes before accumulating in sinusoidal macrophages, Thorotrast in humans is taken up uniformly by the Kupffer cells, and only a small fraction is found in hepatocytes. Thorotrast is redistributed in the liver by aggregation of Thorotrast granules that are found extracellularly and within macrophages. In most cases, Thorotrast aggregation is accompanied by fibrosis that originates in portal areas but eventually involves the hepatic lobules. Further redistribution of Thorotrast results in its markedly nonuniform accumulation in Kupffer cells and in perilobular connective tissue (30, 32) .
Because of the markedly nonuniform distribution of Thorotrast in the liver, the short range of the a particles, the presence of radioactive thorium daughters, and the fibrosis associated with Thorotrast aggregates, accurate estimates of radiation dose to the liver are difficult to determine (16, 17) . With 144 Ce, however, the radiation dose pattern is much more uniform, both because of the more uniform distribution of 144Ce in the liver parenchyma and because of the longer range of 13 particles in the tissue. Also, the exuberant fibrotic response that often accompanies Thorotrast deposition is rarely seen in dogs exposed to 144 Ce. Thus, the average 13 dose to the liver from 144 Ce more accurately reflects the dose to all liver cells than the average liver dose from Thorotrast or plutonium.
Our studies clearly demonstrate that inhalation of 144CeC13, with translocation of 144Ce to the liver, resulted in an increased incidence of primary hepatic neoplasms in dogs. Based on gross and histologic morphologic patterns, the hemangiosarcomas noted are similar to those seen in Thorotrast patients. They also suggest that the latent period of primary hepatic hemangiosarcomas was related to the 13 radiation dose to the liver and that a minimum latent period of approximately 1,800 days preceded death from these tumors.
The hemangiosarcomas in the dogs in this study developed in livers unburdened by the heavy particle loads seen with Thorotrast. These livers also had sinusoidal dilation, peliosis, sinusoidal cell hyperplasia, and sinusoidal fibrosis, changes associated with Thorotrast-induced hemangiosarcomas in humans. The hepatic hemangiosarcomas in these dogs appear to be a direct result of uniform (3 irradiation of the liver. The results indicate that the liver is an important target organ for effects from internally deposited 144 Ce and presumably other hepatotropic 13emitting radionuclides.
